This meeting, organized by the Alzheimer's Drug Discovery Foundation and Alzheimer’s Association, delved into the biological underpinnings that may explain the linkage between cancer and Alzheimer’s. It also provided new avenues for drug discovery.

Sessions focused on current insights from epidemiology, mechanistic and genetic links between cancer and Alzheimer's disease, and therapeutic implications. The goal was to identify specific research questions and linkages needed to advance treatments for Alzheimer's.